NovoCure (NVCR) EBT Margin (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,630.00 |
| Dec 31, 2025 | -553.00 |
| Sep 30, 2025 | 407.00 |
| Jun 30, 2025 | -248.00 |
| Mar 31, 2025 | 1,469.00 |
| Dec 31, 2024 | -2,032.00 |
| Sep 30, 2024 | 120.00 |
| Jun 30, 2024 | 773.00 |
| Mar 31, 2024 | 596.00 |
| Dec 31, 2023 | 907.00 |
| Sep 30, 2023 | 489.00 |
| Jun 30, 2023 | -96.00 |
| Mar 31, 2023 | -1,646.00 |
| Dec 31, 2022 | -748.00 |
| Sep 30, 2022 | -130.00 |
| Jun 30, 2022 | -1,475.00 |
| Mar 31, 2022 | 1,737.00 |
| Dec 31, 2021 | -1,131.00 |
| Sep 30, 2021 | 203.00 |
| Jun 30, 2021 | -788.00 |
| Mar 31, 2021 | -816.00 |
| Dec 31, 2020 | -219.00 |
| Sep 30, 2020 | 483.00 |
| Jun 30, 2020 | 920.00 |
| Mar 31, 2020 | -410.00 |
| Dec 31, 2019 | -302.00 |
| Sep 30, 2019 | 146.00 |
| Jun 30, 2019 | 1,153.00 |
| Mar 31, 2019 | 396.00 |
| Dec 31, 2018 | -373.00 |
| Sep 30, 2018 | 436.00 |
| Jun 30, 2018 | 1,746.00 |
| Mar 31, 2018 | -2,079.00 |
| Dec 31, 2017 | 328.00 |
| Sep 30, 2017 | 3,004.00 |
| Jun 30, 2017 | -80.00 |
| Mar 31, 2017 | -24,455.00 |
| Dec 31, 2016 | 33,971.00 |
| Sep 30, 2016 | 7,040.00 |
| Jun 30, 2016 | 3,798.00 |
| Mar 31, 2016 | 533.00 |
| Dec 31, 2015 | 2,554.00 |
| Sep 30, 2015 | 14,943.00 |
| Jun 30, 2015 | 355.00 |
| Mar 31, 2015 | -135,942.00 |
| Dec 31, 2014 | 133,724.00 |